Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Oct-22 5:00 PM View:  | Aravive, Inc. (ARAV) | 24-Oct-22 | Grant | 16,306,100 | $0.92 | $15,000,000.00 | 177% 9.21M to 25.52M | |
| 04-Apr-22 10:00 PM View: | Aravive, Inc. (ARAV) | 01-Apr-22 | Option Exercise | 4,545,460 | $0.00 | $454.55 | 97% 4.67M to 9.21M | |
| 31-Mar-22 4:06 PM View: | Aravive, Inc. (ARAV) | 29-Mar-22 | Grant | 860,216 | $2.33 | $2,000,000.00 | 23% 3.81M to 4.67M | |
| 22-Nov-21 9:20 AM View: | Eyenovia, Inc. (EYEN) | 17-Nov-21 | Grant | 6,963 | -- | -- | < 1% 1.29M to 1.3M | |
| 17-Feb-21 6:46 PM View: | Aravive, Inc. (ARAV) | 12-Feb-21 | Grant | 2,875,000 | $7.29 | $20,958,800.00 | 309% 931.1K to 3.81M | 15% |
| 15-Sep-20 4:16 PM View: | Eyenovia, Inc. (EYEN) | 11-Sep-20 | Grant | 7,288 | -- | -- | < 1% 1.6M to 1.61M | |
| 20-Aug-19 5:22 PM View: | Eyenovia, Inc. (EYEN) | 16-Aug-19 | Grant | 8,038 | -- | -- | < 1% 1.6M to 1.6M | |
| 26-Jul-18 6:12 PM View: | Eyenovia, Inc. (EYEN) | 24-Jul-18 | Grant | 4,033 | -- | -- | < 1% 1.59M to 1.6M | |
| 04-Jun-18 4:58 PM View: | Medicines Co. (MDCO) | 31-May-18 | Grant | 3,766 | -- | -- | < 1% 2.07M to 2.08M | |
| 06-Feb-18 10:00 AM View: | Eyenovia, Inc. (EYEN) | 29-Jan-18 | Purchase | 335,000 | $10.00 | $3,350,000.00 | 36% 938.43K to 1.27M | |
| 11-Dec-17 6:23 PM View: | Medicines Co. (MDCO) | 08-Dec-17 | Market Purchase | 100,000 | $26.65 | $2,665,000.00 | 5% 1.97M to 2.07M | (7%) |
| 11-Dec-17 6:23 PM View: | Medicines Co. (MDCO) | 07-Dec-17 | Market Purchase | 100,000 | $26.46 | $2,646,000.00 | 5% 1.87M to 1.97M | (6%) |
| 15-Nov-17 5:12 PM View: | G1 Therapeutics, Inc. (GTHX) | 13-Nov-17 | Market Purchase | 250,000 | $19.73 | $4,932,500.00 | 7% 3.44M to 3.69M | 2% |
| 30-May-17 7:43 PM View: | Medicines Co. (MDCO) | 25-May-17 | Grant | 3,237 | -- | -- | < 1% 1.87M to 1.87M | |
| 24-May-17 8:05 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-May-17 | Conversion Duplicate | 3,139,150 | -- | -- | 100% 0 to 3.14M | |
| 24-May-17 8:05 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-May-17 | Purchase Duplicate | 300,000 | $15.00 | $4,500,000.00 | 10% 3.14M to 3.44M | |
| 05-May-17 4:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-May-17 | Grant | 25,406 | -- | -- | 197% 12.89K to 38.3K | |
| 05-May-17 4:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-May-17 | Payment of Exercise | 4,904 | $9.66 | $47,372.60 | (28%) 17.8K to 12.89K | (145%) |
| 08-Dec-16 4:53 PM View: | Medicines Co. (MDCO) | 08-Dec-16 | Market Purchase | 24,689 | $32.66 | $806,380.00 | 1% 1.84M to 1.87M | (24%) |
| 08-Dec-16 4:53 PM View: | Medicines Co. (MDCO) | 07-Dec-16 | Market Purchase | 259,351 | $33.37 | $8,655,310.00 | 16% 1.59M to 1.84M | (26%) |
| 08-Dec-16 4:53 PM View: | Medicines Co. (MDCO) | 06-Dec-16 | Market Purchase | 337,680 | $34.15 | $11,531,800.00 | 27% 1.25M to 1.59M | (27%) |
| 06-Jul-16 7:21 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Jul-16 | Payment of Exercise | 26 | $23.78 | $618.28 | (< 1%) 17.82K to 17.8K | |
| 21-Jun-16 8:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 17-Jun-16 | Grant | 16,726 | -- | -- | 1526% 1.1K to 17.82K | |
| 31-May-16 7:19 PM View: | Medicines Co. (MDCO) | 26-May-16 | Grant | 3,426 | -- | -- | < 1% 1.24M to 1.25M | |
| 13-May-16 5:04 PM View: | Medicines Co. (MDCO) | 12-May-16 | Market Purchase | 300,000 | $33.68 | $10,104,000.00 | 32% 944.54K to 1.24M | (26%) |
| 15-Mar-16 5:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Mar-16 | Grant | 1,096 | -- | -- | 100% 0 to 1.1K | |
| 07-Jul-14 4:40 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 2,673,520 | -- | -- | (94%) 2.85M to 174.5K | |
| 07-Jul-14 4:40 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 174,495 | -- | -- | (100%) 174.5K to 0 | |
| 02-Jul-13 5:47 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 30-Jun-13 | Grant | 7,161 | -- | -- | < 1% 2.84M to 2.85M | |
| 22-Jun-12 4:15 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 21-Jun-12 | Option Exercise | 65,875 | $9.11 | $600,121.00 | 2% 2.77M to 2.84M | |
| 15-Jun-12 4:29 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 14-Jun-12 | Market Purchase | 34,133 | $19.04 | $649,892.00 | 1% 2.74M to 2.77M | 453% |
| 15-Jun-12 4:29 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 13-Jun-12 | Market Purchase | 44,193 | $18.33 | $810,058.00 | 2% 2.7M to 2.74M | 474% |
| 04-Jun-12 4:21 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 01-Jun-12 | Market Purchase | 50,319 | $19.72 | $992,291.00 | 2% 2.65M to 2.7M | 434% |
| 04-Jun-12 4:21 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 31-May-12 | Market Purchase | 70,075 | $20.06 | $1,405,700.00 | 3% 2.58M to 2.65M | 425% |
| 31-May-12 5:01 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 30-May-12 | Market Purchase | 96,321 | $19.87 | $1,913,900.00 | 4% 2.48M to 2.58M | 430% |
| 31-May-12 5:01 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 29-May-12 | Market Purchase | 72,431 | $19.96 | $1,445,720.00 | 3% 2.41M to 2.48M | 427% |
| 29-May-12 4:37 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 25-May-12 | Market Purchase | 1,454 | $18.45 | $26,826.30 | < 1% 2.41M to 2.41M | 471% |
| 25-May-12 4:36 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 24-May-12 | Market Purchase | 27,000 | $17.99 | $485,730.00 | 1% 2.38M to 2.41M | 485% |
| 24-May-12 4:18 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 23-May-12 | Market Purchase | 20,000 | $17.73 | $354,600.00 | < 1% 2.36M to 2.38M | 494% |
| 24-May-12 4:18 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 22-May-12 | Market Purchase | 35,000 | $16.93 | $592,550.00 | 2% 2.32M to 2.36M | 522% |
| 22-May-12 4:58 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 21-May-12 | Market Purchase | 2,400 | $16.15 | $38,760.00 | < 1% 2.32M to 2.32M | 552% |
| 21-May-12 4:59 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 18-May-12 | Market Purchase | 25,000 | $15.28 | $382,000.00 | 1% 2.3M to 2.32M | 589% |
| 19-Mar-12 5:52 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 15-Mar-12 | Market Purchase | 7,102 | $23.91 | $169,809.00 | < 1% 2.29M to 2.3M | 340% |
| 15-Mar-12 5:30 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 14-Mar-12 | Market Purchase | 22,713 | $23.75 | $539,434.00 | 1% 2.27M to 2.29M | 343% |
| 15-Mar-12 5:30 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 13-Mar-12 | Market Purchase | 22,594 | $23.45 | $529,829.00 | 1% 2.24M to 2.27M | 349% |
| 12-Mar-12 6:51 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 12-Mar-12 | Market Purchase | 22,351 | $22.69 | $507,144.00 | 1% 2.15M to 2.17M | 364% |
| 12-Mar-12 6:51 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 09-Mar-12 | Market Purchase | 15,237 | $22.59 | $344,204.00 | < 1% 2.13M to 2.15M | 366% |
| 12-Mar-12 6:51 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 08-Mar-12 | Market Purchase | 14,914 | $22.52 | $335,863.00 | < 1% 2.12M to 2.13M | 367% |
| 07-Mar-12 5:17 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 06-Mar-12 | Market Purchase | 15,237 | $20.87 | $317,996.00 | < 1% 2.1M to 2.12M | 404% |
| 07-Mar-12 5:17 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 05-Mar-12 | Market Purchase | 15,237 | $20.55 | $313,120.00 | < 1% 2.09M to 2.1M | 412% |